Summary
Two patients with cysticercosis received praziquantel (PZQ) 75 mg/kg/day orally together with 30 mg prednisone daily for 3 weeks. The first patient presented with grand-mal seizures, a pyramidal tract syndrome and subcutaneous cysticerci, and the other had internal hydrocephalus necessitating drainage. Serial plasma samples were taken after the first dose of PZQ. Lumbar CSF was obtained from the first patient and ventricular CSF from the second. Subcutaneous cysticerci were removed from the first patient. PZQ in the specimens was assayed by GLC.
For distribution between plasma and CSF a rate constant of 4.9 h−1 for free PZQ, corresponding to a t1/2 of 8 min or less for the non-protein bound fraction was calculated for Patient 1. In the second patient the distribution was so rapid that the rate constant could not be calculated. The difference in distribution rate might have been due to use of different sampling times or to a time lag in the entry of PZQ between the ventricles and the lumbar sac.
The rate constant for distribution of the drug between plasma and parasites was 1.4 h−1, corresponding to a t1/2 of 30 min or less. Thus PZQ penetrates rapidly into the CSF. It enters the parasite more slowly, although still more rapidly than the plasma half-life of PZQ (1–1 1/2 h).
Similar content being viewed by others
References
Mahajan RC (1982) Geographical distribution of human cysticercosis. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, and Beltrán F (eds) Cysticercosis: Present state of knowledge and perspectives. Academic Press, New York, pp 39–46
Dixon HBF, Lipscomb FM (1961) Cysticercosis: An analysis and follow-up of 450 cases. Medical Research Special Report Series no. 299. London, H. M. S. O.
Loo L, Braude A (1982) Cerebral cysticercosis in San Diego. A report of 23 cases and a review of the literature. Medicine (Balt) 61: 341–359
McCormick GF, Zee CS, Heiden J (1982) Cysticercosis cerebri. Review of 127 cases. Arch Neurol 39: 534–539
Seubert J, Pohlke R, Loebich F (1977) Synthesis and properties of praziquantel, a novel broad spectrum anthelminic with excellent activity against schistosomes and cestodes. Experientia 33: 1036
Groll E (1981) Cysticercosis human y praziquantel: Una apreciacion panorámica de los primeros experiencias clínicas. Bol Chil Parasitol 36: 29–37
Botero D, Castano S (1982) Treatment of cysticercosis with praziquantel in Columbia. Am J Trop Med Hyg 31: 810–821
De Ghetaldi LD, Norman RM, Douville AW Jr (1983) Cerebral cysticercosis treated biphasically with dexamethazone and praziquantel. Ann Intern Med 99: 179–181
Pearson RD, Guerrant RL (1983) Praziquantel: A major advance in anthelminthic therapy. Ann Intern Med 99: 195–198
Markwalder K, Hess K, Valavanis A, Witassek F (1981) Cerebral cysticercosis: Treatment with praziquantel. Am J Trop Med Hyg 33: 273–289
Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F (1984) Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 310: 1001–1007
Leopold G, Ungethüm W, Groll E, Diekmann HW, Nowak H, Wegner DHG (1978) Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. Eur J Clin Pharmacol 14: 281–291
Watt G, Long GW, Ranoa CP, Adapon B, Fernando MT, Cross JH (1986) Praziquantel in treatment of cerebral schistosomiasis. Lancet 529–532
Diekmann HW (1979) Quantitative determination of praziquantel in body fluids by gas liquid chromatography. Eur J Drug Metab Pharmacokinet 3: 139–141
Kunst MW, Mattie H (1978) Cefazolin and cephradine: Relationship between serum concentrations and tissue contents in mice. Infection 6: 166–170
Mattie H, Hoogeterp JJ, Hermans J (1987) The relation between plasma and tissue concentrations of antibiotics. Description of a method. J Pharmacokinet Biopharm 15: 191–202
Armitage P (1971) Statistical methods in medical research. Blackwell, Oxford London Edinburgh Melbourne, pp 308–320
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Overbosch, D., van de Nes, J.C.M., Groll, E. et al. Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. Eur J Clin Pharmacol 33, 287–292 (1987). https://doi.org/10.1007/BF00637564
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637564